Stiborová, M.; Černá, V.; Moserová, M.; Mrízová, I.; Arlt, V.M.; Frei, E.
The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes. Int. J. Mol. Sci. 2015, 16, 284-306.
https://doi.org/10.3390/ijms16010284
AMA Style
Stiborová M, Černá V, Moserová M, Mrízová I, Arlt VM, Frei E.
The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes. International Journal of Molecular Sciences. 2015; 16(1):284-306.
https://doi.org/10.3390/ijms16010284
Chicago/Turabian Style
Stiborová, Marie, Věra Černá, Michaela Moserová, Iveta Mrízová, Volker M. Arlt, and Eva Frei.
2015. "The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes" International Journal of Molecular Sciences 16, no. 1: 284-306.
https://doi.org/10.3390/ijms16010284
APA Style
Stiborová, M., Černá, V., Moserová, M., Mrízová, I., Arlt, V. M., & Frei, E.
(2015). The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes. International Journal of Molecular Sciences, 16(1), 284-306.
https://doi.org/10.3390/ijms16010284